150L/H Liquid Dosage, Semi-Solids Homogenizer

Name: 150L/H Liquid Dosage, Semi-Solids Homogenizer
Brand: Antuos Nanotechnology (Su Zhou) Co., Ltd.
SKU: 2148088475

Jiangsu, ChinaAntuos Nanotechnology (Su Zhou) Co., Ltd.

US$32,900.00-36,900.00

1 Piece

Product profile

Customization

Available

Additional Capabilities

Granulating, Milling

After-sales Service

Online Support, video Technical Support

Model NO.

AH12-150

Application

Liquid, Liquid with Suspended Solids, Viscous Fluid

Application Area

Agricultural Chemicals, Chemical, Daily Chemical, Engineering & Construction, Food, Pharmaceutical

Certification

CE, ISO

Condition

New

Control System

Touch Screen Control

Main Material

Stainless Steel

Temperature Control

With Cooling System

Type

Pressure Homogenizer

Warranty

1 year

Rated Pressure

180MPa

Working Pressure

150MPa

Weight

812kg

Specification

1600x 950x1160mm

Trademark

ATS

Origin

China

Production Capacity

5000PCS/Year

Company profile

Importers and ExportersYears of Export ExperienceSelf-brandedExhibition Experience

Antuos Nanotechnology (Su Zhou) Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 10 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤4.40h

AI-Powered supplier vetting

SummaryAntuos Nanotechnology (Su Zhou) Co., Ltd. is a China-based, wholly foreign-owned combined business established in 2014, operating in Suzhou, Jiangsu. It offers high-pressure homogenizers, microfluidizer homogenizers, and extruder systems. The supplier describes itself as a high-tech enterprise integrating R&D, production, and sales, with over 60 employees and a 2,900-square-meter factory, while another record states 50 employees. It reports an ISO 9001:2015 certificate, North American export activity, a one-month off-peak lead time, and experience serving named pharmaceutical companies while meeting FDA certification requirements. Its R&D center provides nanotechnology equipment and technical solutions from experimental to large-scale production. However, most operational, sustainability, quality-control, customization, after-sales, and overseas-service indicators are marked unknown. Audit information identifies SGS, but the reported audit result is “0” and the stated report validity ended on 2025-08-26;...

CertificationsThe supplier reports an ISO 9001:2015 certificate and states that its products meet FDA certification requirements in connection with named pharmaceutical customers. SGS is listed as the audit organization, but the audit result is recorded only as “0,” with no interpretation, and the stated report validity ended on 2025-08-26.

R&D capabilityThe supplier describes a research center for complex-preparation nanotechnology equipment and solutions spanning experimental to large-scale production, and reports three years of total R&D-engineer experience. However, product-information R&D, ODM, SDK, R&D documentation, private-mold, professional-technique, and 3D-design capabilities are all marked unknown.

Production capacityThe supplier offers homogenizer and extruder systems, describes a 2,900-square-meter factory, and reports a one-month off-peak lead time. Nevertheless, outsourcing procedures, manufacturing-capacity contracts, in-stock capacity, overseas warehousing, and order-fulfillment evidence are not substantiated; several are marked unknown.

Client casesThe company description names LEAF Pharmaceuticals in the United States, MYLAN Pharmaceuticals in India, Sun Pharmaceuticals in India, and Aurobindo Pharmaceuticals, stating that requirements related to FDA certification are met. These named references provide evidence of claimed pharmaceutical-sector customer experience, although no project scope, order details, or independently verified case documentation is supplied.